Page last updated: 2024-08-26

1,4-dihydropyridine and Stroke

1,4-dihydropyridine has been researched along with Stroke in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Curti, C; Delgado-Hernández, R; González-Durruthy, M; Marin-Prida, J; Nuñez-Figueredo, Y; Ochoa-Rodríguez, E; Pardo-Andreu, GL; Porto-Verdecia, M; Ramírez-Sánchez, J; Rodrigues, FP; Souza, DO; Uyemura, SA; Verdecia-Reyes, Y	1
van Zwieten, PA	1
Birkenhäger, WH; Bulpitt, CJ; Celis, H; de Leeuw, PW; Fagard, R; Fletcher, AE; Forette, F; Leonetti, G; McCormack, P; Nachev, C; O'Brien, E; Rodicio, JL; Rosenfeld, J; Sarti, C; Staessen, JA; Thijisq, L; Tuomilehto, J; Webster, J; Yodfat, Y; Zanchetti, A	1
Achard, JM; Choukroun, G; Fournier, A; Godefroy, O; Messerli, F; Modeliar, SS; Wang, J	1
Ait-Daoud, N; Devous, MD; Johnson, BA; Ruiz, P	1

Reviews

1 review(s) available for 1,4-dihydropyridine and Stroke

Article	Year
Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. The American journal of psychiatry, 2001, Volume: 158, Issue:8 Topics: Brain Ischemia; Calcium Channel Blockers; Cocaine-Related Disorders; Dihydropyridines; Humans; Isradipine; Stroke; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Vasospasm, Intracranial	2001

Article

Year

Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists.

The American journal of psychiatry, 2001, Volume: 158, Issue:8

Topics: Brain Ischemia; Calcium Channel Blockers; Cocaine-Related Disorders; Dihydropyridines; Humans; Isradipine; Stroke; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Vasospasm, Intracranial

2001

Trials

2 trial(s) available for 1,4-dihydropyridine and Stroke

Article	Year
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. Journal of hypertension, 2004, Volume: 22, Issue:4 Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Incidence; Linear Models; Male; Myocardial Infarction; Nitrendipine; Stroke; Survival Rate; Time Factors; Treatment Outcome	2004
Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention? Stroke, 2006, Volume: 37, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; Blood Pressure; Calcium; Cardiovascular Diseases; Dihydropyridines; Humans; Prevalence; Recurrence; Risk; Stroke; Time Factors; Treatment Outcome	2006

Article

Year

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.

Journal of hypertension, 2004, Volume: 22, Issue:4

Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Incidence; Linear Models; Male; Myocardial Infarction; Nitrendipine; Stroke; Survival Rate; Time Factors; Treatment Outcome

2004

Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?

Stroke, 2006, Volume: 37, Issue:2

Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; Blood Pressure; Calcium; Cardiovascular Diseases; Dihydropyridines; Humans; Prevalence; Recurrence; Risk; Stroke; Time Factors; Treatment Outcome

2006

Other Studies

2 other study(ies) available for 1,4-dihydropyridine and Stroke

Article	Year
JM-20, a novel benzodiazepine–dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro. European journal of pharmacology, 2014, Mar-05, Volume: 726 Topics: Animals; Benzodiazepines; Brain Ischemia; Calcium; Cell Death; Cerebellum; Cytochromes c; Dihydropyridines; Glutamic Acid; Hydrogen Peroxide; Hydrolysis; Liver; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Proton-Translocating ATPases; Mitochondrial Swelling; Neurons; Neuroprotective Agents; Niacin; Oxidative Stress; PC12 Cells; Pentylenetetrazole; Phosphates; Potassium Cyanide; Rats; Stroke	2014
The SYST-EUR study and beyond: immediate versus delayed treatment of isolated systolic hypertension. Journal of hypertension, 2004, Volume: 22, Issue:4 Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Europe; Follow-Up Studies; Humans; Hypertension; Randomized Controlled Trials as Topic; Stroke; Survival Rate	2004

Article

Year

JM-20, a novel benzodiazepine–dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro.

European journal of pharmacology, 2014, Mar-05, Volume: 726

Topics: Animals; Benzodiazepines; Brain Ischemia; Calcium; Cell Death; Cerebellum; Cytochromes c; Dihydropyridines; Glutamic Acid; Hydrogen Peroxide; Hydrolysis; Liver; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Proton-Translocating ATPases; Mitochondrial Swelling; Neurons; Neuroprotective Agents; Niacin; Oxidative Stress; PC12 Cells; Pentylenetetrazole; Phosphates; Potassium Cyanide; Rats; Stroke

2014

The SYST-EUR study and beyond: immediate versus delayed treatment of isolated systolic hypertension.

Journal of hypertension, 2004, Volume: 22, Issue:4

Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Europe; Follow-Up Studies; Humans; Hypertension; Randomized Controlled Trials as Topic; Stroke; Survival Rate

2004